BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24723092)

  • 1. The value of DNA storage and pedigree analysis in rare diseases: a 17-year-old boy with X-linked lymphoproliferative disease (XLP) caused by a de novo SH2D1A mutation.
    Overwater E; Smulders Y; van der Burg M; Lombardi MP; Meijers-Heijboer HE; Kuijpers TW; Houweling AC
    Eur J Pediatr; 2014 Dec; 173(12):1695-8. PubMed ID: 24723092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
    Zhu DX; Du J; Lan HK; Yu L; Feng ZC
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
    Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
    Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
    Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
    J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
    Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
    Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal onset de novo SH2D1A mutation and lymphocytic choriomeningitis virus infection in a patient with X‑linked lymphoproliferative disease type 1: a case report.
    Liu J; Tian W; Wang F; Teng W; Zhang Y; Tong C; Zhang C; Ju Y; Zhang B; Zhao S; Liu H
    Mol Med Rep; 2015 May; 11(5):3291-4. PubMed ID: 25572984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency.
    Aghamohammadi A; Kanegane H; Moein M; Farhoudi A; Pourpak Z; Movahedi M; Gharagozlou M; Zargar AA; Miyawaki T
    Int J Hematol; 2003 Jul; 78(1):45-7. PubMed ID: 12894850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Report of an
    Kesici S; Yılmaz Keskin E; Chiang SC; Kasapkara ÇS; Sekine T; Akçaboy M; Fettah A; Bryceson YT
    Turk J Haematol; 2018 Aug; 35(3):200-202. PubMed ID: 29391328
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
    Morra M; Silander O; Calpe S; Choi M; Oettgen H; Myers L; Etzioni A; Buckley R; Terhorst C
    Blood; 2001 Sep; 98(5):1321-5. PubMed ID: 11520777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
    Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
    Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.
    Soresina A; Lougaris V; Giliani S; Cardinale F; Armenio L; Cattalini M; Notarangelo LD; Plebani A
    Eur J Pediatr; 2002 Dec; 161(12):656-9. PubMed ID: 12447665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
    Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
    Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.